Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 53,967,613 |
|
|||||
| News | (2) | ||||||
| Day High | 0.1118 | Low High |
|||||
| Day Low | 0.098 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ENDRA Life Sciences Inc | NDRA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0208 | 20.59% | 0.1218 | 23:00:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.11 | 0.098 | 0.1118 | 0.1036 | 0.101 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 30,445 | 53,967,613 | US$ 0.1044562 | US$ 5,637,252 | - | 0.0692 - 2.77 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:55 | formt | 1,000 | US$ 0.1218 | USD |
ENDRA Life Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 845.49k | 8.45M | - | 0 | -10.06M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ENDRA Life Sciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/14/2024 | 15:01 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 6/14/2024 | 07:00 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 6/12/2024 | 16:22 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 6/06/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/04/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 6/04/2024 | 08:21 | Business Wire | ENDRA Life Sciences Announces Pricing of $8.0 Million Public.. |
| 5/31/2024 | 15:21 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 5/20/2024 | 07:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/20/2024 | 07:00 | Business Wire | ENDRA Provides Update Following In-person Meeting with FDA |
| 5/14/2024 | 15:26 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/14/2024 | 15:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/14/2024 | 15:05 | Business Wire | ENDRA Life Sciences Reports First Quarter 2024 Financial.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NDRA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.103 | 0.1249 | 0.091 | 0.1075547 | 20,397,979 | 0.0188 | 18.25% |
| 1 Month | 0.2822 | 0.344 | 0.0692 | 0.1280233 | 37,306,268 | -0.1604 | -56.84% |
| 3 Months | 0.9555 | 1.00 | 0.0692 | 0.1310886 | 12,345,534 | -0.8337 | -87.25% |
| 6 Months | 1.52 | 2.77 | 0.0692 | 0.146827 | 5,803,171 | -1.40 | -91.99% |
| 1 Year | 1.52 | 2.77 | 0.0692 | 0.1628654 | 2,933,619 | -1.40 | -91.99% |
| 3 Years | 47.40 | 47.40 | 0.0692 | 2.90 | 1,358,663 | -47.28 | -99.74% |
| 5 Years | 32.20 | 62.00 | 0.0692 | 11.45 | 1,075,199 | -32.08 | -99.62% |
ENDRA Life Sciences Description
| ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. |
